Tenecteplase
Endovascular Treatment
Beijing Tiantan Hospitalprotein_peptidePhase 3Active
B
62/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 49/ 100
- Competitive Position
- 89/ 100
Competitive context
7 Active assets in the Endovascular Treatment cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Arestin Xijing Hospital | Phase 4 | BB |
Tirofiban Shandong Provincial Hospital | Phase 3 | B |
Semaglutide Wei Hu | Phase 3 | B |
Tocilizumab Suzhou Municipal Hospital of Anhui Province | Phase 2/3 | B |
PHYSIOLOGIC SODIUM CHLORIDE SOLUTION Suzhou Municipal Hospital of Anhui Province | Phase 2/3 | B |
View all 9 →
Same molecule, other indications
Tenecteplase is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →